THE VALUE OF CLINICAL TRIAL RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Roth, Joshua A. [1 ]
Carlson, Josh J. [1 ]
Steuten, Lotte [2 ]
Ramsey, Scott D. [3 ]
Veenstra, David L. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Twente, NL-7500 AE Enschede, Netherlands
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
ERCC1; Value of Research; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 50 条
  • [31] Association of EGFR mutations with ERCC1 expression in non-small cell lung cancer.
    Liang, Wenhua
    Lin, Ziying
    Xu, Yutong
    Zhang, Yaxiong
    He, Jianxing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)
    Gwon, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S520 - S521
  • [33] Racial disparities in biomarker testing and clinical trial enrollment in non-small cell lung cancer (NSCLC).
    Bruno, Debora S.
    Hess, Lisa M.
    Li, Xiaohong
    Su, Eric Wen
    Zhu, Yajun Emily
    Patel, Monaliben
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Non-small cell lung cancers:: ERCC1, a therapeutic biomarker in view
    Benard, Jean
    BULLETIN DU CANCER, 2006, 93 (11) : 1086 - 1086
  • [35] ERCC1 expression of small cell lung cancer
    Hennemann, Marluce
    Sostruznik, Maria H.
    Gaiger, Ana
    Barrios, Carlos H.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S807 - S807
  • [36] Prognostic and predictive role of ERCC1 protein expression in locally advanced stage III non-small cell lung cancer
    Lamiss Mohamed Sad
    Samar Galal Younis
    Mohamed Mosad Elity
    Medical Oncology, 2014, 31
  • [37] Expression levels of ERCC1 and RRM1 mRNA and clinical outcome of advanced non-small cell lung cancer
    Bi Jian-wei
    Mao Yi-min
    Sun Yu-xia
    Liu Shi-qing
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (05) : 1158 - 1161
  • [38] ERCC1 and RRM1 but not EGFR gene expression is predictive of shorter survival in advanced non-small cell lung cancer (NSCLC).
    Selvaggi, G.
    Ceppi, P.
    Volante, M.
    Saviozzi, S.
    Novello, S.
    Calogero, R.
    Papotti, M.
    Scagliotti, G. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 548S - 548S
  • [39] Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer (NSCLC)
    Yoshino, I.
    Takenaka, T.
    Koso, H.
    Ohba, T.
    Yohena, T.
    Osoegawa, A.
    Shoji, F.
    Maehara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Prognostic and predictive role of ERCC1 protein expression in locally advanced stage III non-small cell lung cancer
    Sad, Lamiss Mohamed
    Younis, Samar Galal
    Elity, Mohamed Mosad
    MEDICAL ONCOLOGY, 2014, 31 (07)
12345